MEI Pharma secures over $100 million in funding commitments to launch the Litecoin treasury strategy

ChainCatcher news indicates that, according to information from Titan Partners Group and cryptocurrency investment firm GSR, the American pharmaceutical company MEI Pharma (NASDAQ: MEIP) is advancing its strategy to establish a dedicated Litecoin treasury. Currently, over $100 million in funding commitments have been made for this project.

It is worth mentioning that Litecoin founder Charlie Lee has agreed to join the board of MEI Pharma.

In addition, the Litecoin Foundation has also invested in MEI Pharma, as the company's treasury strategy aligns closely with the core mission of the Litecoin Foundation to promote global Litecoin adoption.